Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

2019-07-04T21:11:12+00:00May 8th, 2018|Categories: Press Releases|Tags: , , , , , , |

⟵  PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]